갱년기 장애 시장 규모, 점유율, 성장 분석 : 치료법별, 제품 유형별, 적응증별, 유통상 과제별, 연령층별, 지역별 - 산업 예측(2025-2032년)
Menopause Market Size, Share, and Growth Analysis, By Treatment (Dietary Supplements, OTC Pharma Products), By Product Type (Gel, Injection), By Indication, By Distribution Challenge, By Age Group, By Region - Industry Forecast 2025-2032
상품코드:1677901
리서치사:SkyQuest Technology Consulting Pvt. Ltd.
발행일:2025년 03월
페이지 정보:영문 219 Pages
라이선스 & 가격 (부가세 별도)
한글목차
세계의 갱년기 장애 시장 규모는 2023년에 186억 달러에 달하며, 예측 기간(2025-2032년)의 CAGR은 6.0%로, 2024년 197억 2,000만 달러에서 2032년에는 314억 2,000만 달러로 성장할 전망입니다.
갱년기 시장은 상당수의 여성들이 경험하는 안면홍조, 식은땀, 우울감 등 갱년기 증상을 완화하는 제품에 대한 인식과 수요가 증가하면서 45세에서 55세 사이의 자연적 생물학적 변화로 인해 증상 완화를 위한 건강기능식품, 허브, 시판 의약품에 대한 관심이 급증하고 있습니다. 건강보조식품, 허브 제품, 일반의약품에 대한 관심이 급증했습니다. 인구 고령화, 건강 의식 증가, 자연 및 유기농 솔루션으로의 전환 등이 이러한 성장의 원동력이 되고 있으며, COVID-19 팬데믹은 이러한 추세를 더욱 강화하여 정신건강을 방해하고 여성들이 호르몬 대체요법에 대한 안전한 식물성 대안을 찾고 영양 및 건강 보조 식품의 사용을 증가시키는 결과를 가져왔습니다. 영양 보충제의 사용량을 증가시켰습니다. 이러한 진화하는 환경은 지속적인 시장 확대의 기회를 시사하고 있습니다.
목차
서론
조사의 목적
조사 범위
정의
조사 방법
정보 조달
2차와 1차 데이터 방법
시장 규모 예측
시장의 전제조건과 제한
개요
세계 시장 전망
공급과 수요 동향 분석
부문별 기회 분석
시장 역학과 전망
시장 개요
시장 규모
시장 역학
촉진요인과 기회
억제요인과 과제
Porter의 산업 분석
주요 시장 인사이트
주요 성공 요인
경쟁의 정도
주요 투자 기회
시장 에코시스템
시장의 매력 지수(2024년)
PESTEL 분석
거시경제 지표
밸류체인 분석
가격 분석
갱년기 장애 시장 규모 : 치료법별 & CAGR(2025-2032)
시장 개요
식이보충제
일반의약품
호르몬 제품
에스트로겐과 기타 약제 병용
에스트로겐과 프로게스틴 병용약
에스트로겐 온리 약
프로게스틴 온리 약
비호르몬 제품
갱년기 장애 시장 규모 : 제품 유형별 & CAGR(2025-2032)
시장 개요
겔
주사
경구투여량
패치
필
분말
스킨 크림
스킨 스프레이(경피)
질 크림
질링
갱년기 장애 시장 규모 : 적응증별 & CAGR(2025-2032)
시장 개요
안구건조증
건성피부
열감(Hot Flashes)
심한 감정 변화, 경우울증, 과민성
식은땀과 한기
골다공증
수면장애
요절박
질 건조
갱년기 장애 시장 규모 : 유통상 과제별 & CAGR(2025-2032)
시장 개요
병원 약국
온라인 스토어
소매 약국
갱년기 장애 시장 규모 : 연령층별 & CAGR(2025-2032)
시장 개요
조기 갱년기 장애
초기 갱년기 장애
평균 갱년기 장애
후기 갱년기 장애
갱년기 장애 시장 규모 : 지역별 & CAGR(2025-2032)
북미
미국
캐나다
유럽
독일
스페인
프랑스
영국
이탈리아
기타 유럽 지역
아시아태평양
중국
인도
일본
한국
기타 아시아태평양
라틴아메리카
브라질
기타 라틴아메리카 지역
중동 및 아프리카
GCC 국가
남아프리카공화국
기타 중동 및 아프리카
경쟁 정보
상위 5사의 비교
주요 기업의 시장 포지셔닝(2024년)
주요 시장 기업이 채택한 전략
최근 시장 동향
기업의 시장 점유율 분석(2024년)
주요 기업의 기업 개요
기업의 상세
제품 포트폴리오 분석
기업의 부문별 점유율 분석
매출의 전년대비 비교(2022-2024)
주요 기업 개요
AbbVie Inc.(USA)
Astellas Pharma Inc.(Japan)
Bayer AG(Germany)
Pfizer Inc.(USA)
Novartis AG(Switzerland)
Merck & Co., Inc.(USA)
Teva Pharmaceutical Industries Ltd.(Israel)
Eli Lilly and Company(USA)
GlaxoSmithKline plc(UK)
Key Developments
Mithra Pharmaceuticals(Belgium)
Dr. Reddy's Laboratories Ltd.(India)
Procter & Gamble(USA)
Unilever(UK)
Pure Encapsulations, LLC(USA)
Rainbow Light(USA)
Kindra(USA)
Elektra Health(USA)
결론과 제안
KSA
영문 목차
영문목차
Global Menopause Market size was valued at USD 18.6 billion in 2023 and is poised to grow from USD 19.72 billion in 2024 to USD 31.42 billion by 2032, growing at a CAGR of 6.0% during the forecast period (2025-2032).
The menopause market is on an upward trajectory, reflecting heightened awareness and demand for products that alleviate menopausal symptoms such as hot flashes, night sweats, and mood swings, experienced by a significant percentage of women. Spanning ages 45 to 55, this natural biological transition has prompted a surge in interest for nutritional supplements, herbal products, and over-the-counter medications designed to ease symptoms. Factors fueling this growth include an aging population, increased health consciousness, and a shift toward natural and organic solutions. The COVID-19 pandemic has further intensified these trends, disrupting mental health and prompting women to seek safe, plant-based alternatives to hormone replacement therapy, resulting in a boost in dietary supplement usage. This evolving landscape signals sustained market expansion opportunities.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Menopause market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Menopause Market Segments Analysis
Global Menopause Market is segmented by Treatment, Product Type, Indication, Distribution Challenge, Age Group and region. Based on Treatment, the market is segmented into Dietary Supplements and OTC Pharma Products. Based on Product Type, the market is segmented into Gel, Injection, Oral Dosage, Patch, Pill, Powder, Skin Cream, Skin Spray (Transdermal), Vaginal Cream and Vaginal Ring. Based on Indication, the market is segmented into Dry Eyes, Dry Skin, Hot Flashes, Mood Swings, Mild depression & Irritability, Night Sweats and Cold Flashes., Osteoporosis, Trouble Sleeping, Urinary Urgency and Vaginal Dryness. Based on Distribution Challenge, the market is segmented into Hospital Pharmacies, Online Stores and Retail Pharmacies. Based on Age Group, the market is segmented into Premature Menopause, Early Menopause, Average Menopause and Late Menopause. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Menopause Market
The global menopause market is fueled by several key factors, including the aging population, increased awareness, lifestyle changes, and advancements in technology. As life expectancies rise and birth rates decline, more women are entering menopause, creating a substantial demand for menopause-related products and services. For example, the North American Menopause Association reports that about 2 million women in the U.S. go through menopause each year. Additionally, public awareness of menopause symptoms is improving, leading to greater demand for solutions like hormone therapy, herbal supplements, and wellness products. Women are also acknowledging the role of healthy lifestyles in managing menopause symptoms, further driving market growth.
Restraints in the Global Menopause Market
Despite the substantial growth potential in the Global Menopause market, several factors may act as constraints on its expansion. Safety concerns regarding hormone replacement therapy (HRT), particularly its links to increased risks of breast cancer, heart disease, and stroke, are paramount. Consequently, there is a growing demand for non-hormonal alternatives, creating challenges for companies focusing on hormone-based therapies to address these safety issues. Additionally, menopause remains a stigmatized topic in many cultures, leading to a lack of awareness and understanding that can suppress consumer demand and complicate marketing efforts for menopause-related products. Regulatory hurdles impose strict safety and efficacy requirements, further deterring innovation in treatment options. Compounded by insufficient research and development in this field, these factors collectively threaten to hinder the market's advancement.
Market Trends of the Global Menopause Market
The Global Menopause market is witnessing a significant shift towards non-hormonal therapies driven by women's growing apprehension regarding hormone-based treatments and their associated risks. This trend has led to a rising demand for alternative solutions, such as herbal medicines, cognitive-behavioral therapy (CBT), and mindfulness-based interventions, which are perceived as safer options for managing menopausal symptoms. As awareness around holistic health and wellness increases, healthcare providers and companies are focusing on developing and promoting these non-hormonal alternatives, further shaping the market landscape. This evolution highlights a consumer preference for natural and integrative approaches, signaling a transformative era in menopause management strategies.
Table of Contents
Introduction
Objectives of the Study
Scope of the Report
Definitions
Research Methodology
Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations
Executive Summary
Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis
Market Dynamics & Outlook
Market Overview
Market Size
Market Dynamics
Drivers & Opportunities
Restraints & Challenges
Porters Analysis
Competitive rivalry
Threat of substitute
Bargaining power of buyers
Threat of new entrants
Bargaining power of suppliers
Key Market Insights
Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Global Menopause Market Size by Treatment & CAGR (2025-2032)
Market Overview
Dietary Supplements
OTC Pharma Products
Hormonal products
Combination Estrogen and Other Medicines
Combination Estrogen and Progestin Medicines
Estrogen-Only Medicines
Progestin-Only Medicines
Non-hormonal products
Global Menopause Market Size by Product Type & CAGR (2025-2032)
Market Overview
Gel
Injection
Oral Dosage
Patch
Pill
Powder
Skin Cream
Skin Spray (Transdermal)
Vaginal Cream
Vaginal Ring
Global Menopause Market Size by Indication & CAGR (2025-2032)
Market Overview
Dry Eyes
Dry Skin
Hot Flashes
Mood Swings, Mild depression & Irritability
Night Sweats and Cold Flashes.
Osteoporosis
Trouble Sleeping
Urinary Urgency
Vaginal Dryness
Global Menopause Market Size by Distribution Challenge & CAGR (2025-2032)
Market Overview
Hospital Pharmacies
Online Stores
Retail Pharmacies
Global Menopause Market Size by Age Group & CAGR (2025-2032)
Market Overview
Premature Menopause
Early Menopause
Average Menopause
Late Menopause
Global Menopause Market Size & CAGR (2025-2032)
North America (Treatment, Product Type, Indication, Distribution Challenge, Age Group)
US
Canada
Europe (Treatment, Product Type, Indication, Distribution Challenge, Age Group)
Germany
Spain
France
UK
Italy
Rest of Europe
Asia Pacific (Treatment, Product Type, Indication, Distribution Challenge, Age Group)
China
India
Japan
South Korea
Rest of Asia-Pacific
Latin America (Treatment, Product Type, Indication, Distribution Challenge, Age Group)
Brazil
Rest of Latin America
Middle East & Africa (Treatment, Product Type, Indication, Distribution Challenge, Age Group)
